Prime Minister Justin Trudeau addressed media from Ottawa on Monday, providing updates to the federal response to COVID-19.
Early Monday morning, Pfizer announced that its vaccine candidate had shown a resounding 90 percent effectiveness, with little or no side effects. Trudeau said that while he hopes to see the vaccine available to Canadians by early in the spring, he warns that we aren't quite out of the woods yet.
Trudeau called the news "encouraging," but pointed to record highs in cases across Canada, including in Ontario, which saw 1,328 new cases announced on Mondays.
Asked about Pfizer’s vaccine candidate, reported to be 90% effective in preventing #COVID19, PM Trudeau says Canada’s pre-ordered doses could be distributed in the first quarter of 2021, beginning with high-priority groups. #cdnpoli https://t.co/ChtXAJ33b7
— CPAC (@CPAC_TV) November 9, 2020
The Canadian government purchased over 70 million doses of candidate vaccines from several companies earlier this year, including 20 million of Pfizer's. Trudeau said that if the vaccine was given the green light from Health Canada, more doses would be purchased.
“We hope to see vaccines landing in the early next year but between now and then it's really really important that we double down on our efforts,” said Trudeau.
“We need to make sure we are controlling the spread of COVID-19 in the coming months so that when vaccines get here we will be able to act quickly to protect all Canadians.”
Join and support independent free thinkers!
We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.
Remind me next month
To find out what personal data we collect and how we use it, please visit our Privacy Policy
